AMH and Schnyder corneal dystrophy: Another study, based on 285 banked serum samples from 93 HbSS women, of which 86 out of 93 were exposed to hydroxyurea (a disease-modifying therapy for SCD that reduces the frequency of vaso-occlusive crises, and need for blood transfusion), found a reduction in serum AMH concentrations.